Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Amgen
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Acquisitions == {{hidden start|toggle=left|title=The following is an illustration of the company's major mergers and acquisitions and historical predecessors (this is not a comprehensive list):|titlestyle=background:white;}} {{Tree list}} *'''Amgen''' <small>(Founded 1983 as Applied Molecular Genetics)</small> **Synergen Inc <small>(Acq 1994)</small><ref>{{cite news |last1=Olmos |first1=David |title=Amgen to Acquire Synergen in $239-Million Biotech Deal|url=https://www.latimes.com/archives/la-xpm-1994-11-19-fi-64446-story.html|access-date=4 November 2024 |work=Los Angeles Times |date=19 November 1994|language=en}}</ref> **Kinetix Pharmaceuticals Inc <small>(Acq 2000)</small><ref>{{cite news |last1=Murphy |first1=Barbara |title=Amgen Agrees to Buy Drug Maker Kinetix|url=https://www.latimes.com/archives/la-xpm-2000-oct-24-me-41036-story.html|access-date=4 November 2024 |work=Los Angeles Times |date=24 October 2000|language=en}}</ref> **Immunex Corporation <small>(Acq 2002)</small> **Tularik Inc <small>(Acq 2004)</small> **Abgenix Inc <small>(Acq 2006)</small> **Avidia Inc <small>(Acq 2006)</small><ref>{{cite news |title=Amgen Agrees to Acquire Biotech Company Avidia |url=https://www.wsj.com/articles/SB115953920781877969|access-date=27 January 2025 |work=The Wall Street Journal |date=29 September 2006|language=en}}</ref> **Alantos Pharmaceuticals <small>(Acq 2007)</small><ref>{{cite news |title=Amgen to Acquire Alantos Pharmaceuticals|url=https://www.technologynetworks.com/drug-discovery/news/amgen-to-acquire-alantos-pharmaceuticals-186303|access-date=27 January 2025 |work=Technology Networks |date=8 June 2007|language=en}}</ref> **Ilypsa Inc <small>(Acq 2007)</small><ref>{{cite news |title=Amgen to Acquire Ilypsa for $420M |url=https://www.genengnews.com/news/amgen-to-acquire-ilypsa-for-420m/|access-date=27 January 2025 |work=GEN|date=5 June 2007|language=en}}</ref> **BioVex Group Inc <small>(Acq 2011)</small> **Micromet Inc <small>(Acq 2012)</small> **Mustafa Nevzat Δ°laΓ§ <small>(Acq 2012)</small> **KAI Pharmaceuticals <small>(Acq 2012)</small> **[[deCODE genetics]] <small>(Acq 2012)</small> **[[Onyx Pharmaceuticals]] <small>(Acq 2013)</small> ***[[Proteolix]]<small>(Acq 2009) </small> **NextCODE genetics <small>(Spun off 2013)</small> **Dezima Pharma <small>(Acq 2015)</small> **Catherex <small>(Acq 2015)</small><ref>{{cite news|title=Medigene AG: Amgen acquires Medigene spin-off Catherex |url=https://www.fiercebiotech.com/biotech/medigene-ag-amgen-acquires-medigene-spin-off-catherex|access-date=23 October 2024 |work=Fierce Biotech|date=21 December 2015 |language=en}}</ref> **Nuevolution AB <small>(Acq 2019)</small> **Otezla ([[apremilast]]) <small>(Acq 2019)</small><ref>{{cite news |last1=Erman |first1=Michael |last2=Mishra |first2=Manas |title=Amgen to buy Celgene psoriasis drug Otezla for $13.4 billion |url=https://www.reuters.com/article/us-bristol-myers-divestiture-amgen/amgen-to-buy-celgene-psoriasis-drug-otezla-for-13-4-billion-idUSKCN1VG102 |access-date=23 September 2022 |work=Reuters |date=26 August 2019 |language=en}}</ref> **Five Prime Therapeutics <small>(Acq 2021)</small><ref>{{cite news |last1=Adams |first1=Ben |title=Prime time for Five Prime as Amgen snaps up this once-moribund biotech for $1.9B and its phoenix-from-the-flames cancer asset |url=https://www.fiercebiotech.com/biotech/amgen-pays-a-premium-for-five-prime-therapeutics-a-1-9b-cash-deal |access-date=23 September 2022 |work=Fierce Biotech |date=4 March 2021 |language=en}}</ref> **Rodeo Therapeutics Corporation <small>(Acq 2021)</small><ref>{{cite news |last1=Idrus |first1=Amirah Al |title=Amgen saddles up with Rodeo for a $55M trek into regenerative medicine |url=https://www.fiercebiotech.com/biotech/amgen-drops-55m-upfront-for-rodeo-therapeutics-and-its-prostaglandin-blockers |access-date=23 September 2022 |work=Fierce Biotech |date=30 March 2021 |language=en}}</ref> **Teneobio <small>(Acq 2021)</small> **ChemoCentryx <small>(Acq 2022)</small><ref>{{cite news |last1=Philippidis |first1=Alex |title=Amgen to Acquire ChemoCentryx for $3.7B, Bolstering Autoimmune Portfolio |url=https://www.genengnews.com/topics/drug-discovery/therapeutics/autoimmune-disease-drugs/amgen-to-acquire-chemocentryx-for-3-7b-bolstering-autoimmune-portfolio/ |access-date=23 September 2022 |work=GEN - Genetic Engineering and Biotechnology News |date=5 August 2022}}</ref> **[[Horizon Therapeutics]] <small>(Acq 2023)</small> ***Vidara Therapeutics International <small>(Acq 2014)</small> ***Hyperion Therapeutics <small>(Acq 2015)</small> ***Crealta Holdings <small>(Acq 2015)</small> ***Raptor Pharmaceutical <small>(Acq 2016)</small> ***River Vision Development Corp. <small>(Acq 2017)</small> ***Viela Bio Inc <small>(Acq 2021)</small><ref>{{cite news |last1=Bell|first1=Jacob|last2=Fidler|first2=Ben |title=Horizon acquires Viela Bio for $3B in a windfall for AstraZeneca|url=https://www.biopharmadive.com/news/horizon-acquires-astrazeneca-spinout-viela-bio/594265/ |access-date=20 December 2024 |work=Biopharma Dive |date=1 February 2021}}</ref> {{Tree list/end}} {{hidden end}}
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)